References
- Åkerlund B, Carlson L A, Jarstrand C. Dyslipoproteinemia in patients with severe bacterial infections. Scand J Infect Dis 1986; 18: 539–45
- Sammalkorpi K, Valtonen V, Kerttula Y, Nikkilä E A, Taskinen M ‐R. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 38: 859–65
- Benditt E P, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977; 74: 4025–8
- Benditt E P, Hoffman J S, Eriksen N. SAA, an apoprotein of HDL: its structure and function. Ann NY Acad Sci 1982; 389: 183–9
- Coetzee G A, Strachan A F, van der Westhuyzen D R, Hoppe H C, Jeenah M S, de Beer F C. Serum amyloid A‐containing human high density lipoprotein 3. J Biol Chem 1986; 261: 9644–51
- de Beer F C, Soutar A K, Baltz M L, Trayner I M, Feinstein A, Pepy M B. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C‐reactive protein. J Exp Med 1982; 156: 230–42
- Khosla T, Lowe C R. Indices of obesity derived from body weight and height. Br J Prev Soc Med 1967; 21: 122–8
- Havel R J, Eder H A, Bragdon J H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
- Huttunen J K, Ehnholm C, Kinnunen P J, Nikkilä E A. An immunochemical method for selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 1975; 63: 335–47
- Röschlau P, Bemt E, Gruber E. Enzymatische bestimmung des gesamtcholesterins in serum. Z Klin Chem Klin Biochem 1974; 12: 403–7
- Wahlefeld A W. Triglyceride determination after enzymatic hydrolysis. Methods of enzymatic analysis2nd ed., H V Bergmeyer. Academic Press, New York 1974; 1831–95
- Kashyap M R, Hynd B A, Robinson K. A rapid and simple method for measurement of total protein in very low density lipoproteins by Lowry assay. J Lipid Res 1980; 21: 491–5
- Dixon W J. BMDP statistical software. University of California Press, Berkeley 1981
- Pepys M B, Baltz M L. Acute phase proteins with special reference to C‐reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141–212
- Rowe I F, Soutar A K, Trayner I M, Thompson G R. Circulating human C‐reactive protein binds very low density lipoproteins. Clin Exp Immunol 1984; 58: 237–44
- Svenson K LG, Lithell H, Hällgren R, Selinus I, Vessby B. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med 1987; 147: 1912–6
- Robin A P, Nordenström J, Askanazi J, Elwyn D H, Carpentier Y A, Kinney J M. Plasma clearance of fat emulsion in trauma and sepsis: use of a three‐stage lipid clearance test. JPEN 1980; 4: 81–6
- Brown M S, Goldstein J L. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983; 52: 223–61
- Clifton P M, Mackinnon A M, Barter P J. Effects of serum amyloid A protein (SAA) on composition, size and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res 1985; 26: 1389–98
- Cabana V G, Siegel J N, Sabesin S M. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989; 30: 39–49
- Parks J S, Rudel L L. Metabolism of the serum amyloid A proteins (SAA) in high‐density lipoproteins and chylomicrons of nonhuman primates (vervet monkey). Am J Pathol 1983; 112: 243–9
- Hoffman J F, Benditt E P. Plasma clearance kinetics of the amyloid‐related high density lipoprotein apoprotein, serum amyloid protein (apoSAA) in the mouse. Evidence for rapid apoSAA clearance. J Clin Invest 1983; 71: 926–34